What is NDC 69315-292?

69315-292 is the product NDC for Allopurinol, Allopurinol 300 mg/1 tablet, listed with the FDA by Leading Pharma, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Leading Pharma, LLC, NDC labeler code 69315. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Allopurinol?

167 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Allopurinol NDC 69315-292 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69315-292Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69315-0292Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
69315-292-01	69315029201	100 TABLET in 1 BOTTLE (69315-292-01)Marketed from May 1, 2024
69315-292-05	69315029205	500 TABLET in 1 BOTTLE (69315-292-05)Marketed from May 1, 2024
69315-292-10	69315029210	1000 TABLET in 1 BOTTLE (69315-292-10)Marketed from May 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Allopurinol
Generic name (nonproprietary): allopurinol
Active ingredients: Allopurinol — 300 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Leading Pharma, LLCNDC labeler code 69315
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214443
Marketing start: May 1, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Xanthine Oxidase Inhibitors (Mechanism)
Identifiers: Product ID 69315-292_227ef709-80a3-45e9-807a-2db8abee3a50SPL ID 227ef709-80a3-45e9-807a-2db8abee3a50
Pharmacologic class: Xanthine Oxidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469315029201 followed by a unit qualifier and the quantity

Package 69315-0292-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 69315-292

What is NDC 69315-292?: 69315-292 is the product NDC for Allopurinol, Allopurinol 300 mg/1 tablet, listed with the FDA by Leading Pharma, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Allopurinol.
What is the active ingredient?: Allopurinol.
Who is the labeler?: Leading Pharma, LLC, NDC labeler code 69315. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Allopurinol?: 167 other product NDCs are listed under this name. See all Allopurinol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Allopurinol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Allopurinol	Allopurinol 300 mg/1	TabletOral	Cardinal Health 107, LLC	55154-0282	55154-0282-00
Allopurinol	Allopurinol 300 mg/1	TabletOral	REMEDYREPACK INC.	70518-4693	70518-4693-00
Allopurinol	Allopurinol 100 mg/1	TabletOral	Safecor Health, LLC	48433-002	48433-0002-20
Allopurinol	Allopurinol 300 mg/1	TabletOral	Safecor Health, LLC	48433-003	48433-0003-20
Allopurinol	Allopurinol 300 mg/1	TabletOral	Coupler LLC	67046-1658	67046-1658-03
Allopurinol	Allopurinol 300 mg/1	TabletOral	REMEDYREPACK INC.	70518-4556	70518-4556-00
Allopurinol	Allopurinol 300 mg/1	TabletOral	Northwind Health Company, LLC	82868-099	82868-0099-3082868-0099-90
Allopurinol	Allopurinol 100 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	53401-019	53401-0019-6053401-0019-80
Allopurinol	Allopurinol 300 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	53401-025	53401-0025-60
Allopurinol	Allopurinol 100 mg/1	TabletOral	XLCare Pharmaceuticals Inc.	72865-303	72865-0303-0172865-0303-0572865-0303-10+1 more

All 168 Allopurinol NDCs

Other NDCs under ANDA 214443

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214443
Product	Strength	Form · route	Labeler	Product NDC
Allopurinol	Allopurinol 100 mg/1	TabletOral	ST. MARY'S MEDICAL PARK PHARMACY	60760-710
Allopurinol	Allopurinol 300 mg/1	TabletOral	Coupler LLC	67046-1639
Allopurinol	Allopurinol 300 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-3672
Allopurinol	Allopurinol 100 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-3803
Allopurinol	Allopurinol 300 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8713
Allopurinol	Allopurinol 100 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8727
Allopurinol	Allopurinol 100 mg/1	TabletOral	Leading Pharma, LLC	69315-291
Allopurinol	Allopurinol 200 mg/1	TabletOral	Leading Pharma, LLC	69315-409
Allopurinol	Allopurinol 100 mg/1	TabletOral	Bryant Ranch Prepack	71335-2542
Allopurinol	Allopurinol 100 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-949
Allopurinol	Allopurinol 100 mg/1	TabletOral	Harman Finochem Limited	82638-112
Allopurinol	Allopurinol 300 mg/1	TabletOral	Harman Finochem Limited	82638-113